Accession Number: | 0001209191-21-039092 |
Date: | 2021-06-08 |
Issuer: | SIERRA ONCOLOGY, INC. (SRRA) |
Original Submission Date: |
PELZER ROBERT
C/O SIERRA ONCOLOGY, INC.
1820 GATEWAY DRIVE, SUITE 110
SAN MATEO, CA 94404
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 18.11 | 2021-06-08 | deemed execution date | A | 6,000 (a) | 2031-06-08 | common stock 6,000 | $18.11 | 6,000 | direct |
ID | footnote |
---|---|
f1 | the option fully vests and becomes exercisable on june 8, 2022, subject to the reporting person's provision of service to the issuer as of the vesting date. |